Nano-enabled medical applications / (Record no. 129445)

000 -LEADER
fixed length control field 05320cam a2200553Ki 4500
001 - CONTROL NUMBER
control field 9780429399039
003 - CONTROL NUMBER IDENTIFIER
control field FlBoTFG
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220509193100.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |n|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200913s2021 si o 000 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency OCoLC-P
Language of cataloging eng
Description conventions rda
Transcribing agency OCoLC-P
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0429677901
-- electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780429677892
-- electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0429677898
-- electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780429677885
-- electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 042967788X
-- electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780429399039
-- electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0429399030
-- electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780429677908
-- (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9789814800327
-- hardcover
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9814800325
-- hardcover
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1194960602
Canceled/invalid control number (OCoLC)1195441736
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC-P)1194960602
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number R857.N34
Item number N36 2021eb
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 009000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code SCI
Subject category code subdivision 010000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code TBN
Source bicssc
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 610.28
Edition number 23
245 00 - TITLE STATEMENT
Title Nano-enabled medical applications /
Statement of responsibility, etc edited by Lajos P. Balogh.
264 #1 -
-- Singapore :
-- Jenny Stanford Publishing Pte. Ltd.,
-- [2021]
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
490 1# - SERIES STATEMENT
Series statement Nanomedicine's most cited ;
Volume number/sequential designation volume 2
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Cover -- Half Title -- Series Page -- Title Page -- Copyright Page -- Contents -- Preface -- 1 Intelligent Nanomaterials for Medicine: Carrier Platforms and Targeting Strategies-State of the Art -- 1.1 Introduction -- 1.2 Nanotechnology Carrier Platforms Suited for Switch Functionality -- 1.2.1 Micelles and Liposomes -- 1.2.2 Polymeric Systems -- 1.2.3 Dendrimers -- 1.2.4 Carbon Nanotubes -- 1.2.5 Metallic Nanoparticles -- 1.2.6 Other Organic Nanoparticles: Carbohydrate-Based NPs, e.g., Chitosan and Starch -- 1.2.7 Quantum Dots and Carbon Quantum Dots -- 1.2.8 Nanogels
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 1.2.9 Peptide-Based Nanoparticles as Delivery System -- 1.3 Advanced Functionality Including Internal and External Stimuli-Responsiveness -- 1.4 Engineering Cell and Tissue Interaction at the Nanoscale -- 1.4.1 Targeting Strategies -- 1.4.1.1 Passive targeting -- 1.4.1.2 Active targeting -- 1.4.2 Endocytotic Cellular Uptake -- 1.4.3 Cellular Uptake by Cell-Penetrating Peptides -- 1.4.4 Endosomal Escape -- 1.4.5 Exocytosis -- 1.5 Clinical Application of Nanomaterials -- 1.5.1 The Clinical Trial Landscape: An Emphasis on Cancer
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 1.5.2 Potential Risk Factors Regarding Approved Nanoparticle-Based Therapies -- 1.6 Conclusions and Outlook -- 2 Nanocarriers as an Emerging Platform for Cancer Therapy -- 2.1 Passive and Active Targeting -- 2.2 Types of Targeting Agents -- 2.3 The Arsenal of Nanocarriers -- 2.4 The Challenges of Multidrug Resistance -- 2.5 Into the Future -- 3 Microfluidic Technologies for Accelerating the Clinical Translation of Nanoparticles -- 3.1 Well-Controlled Synthesis of Nanoparticles -- 3.2 Evaluation and Screening of Nanoparticles -- 3.3 Future Prospects -- 4 Theranostic Nanomedicine
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 4.1 Introduction -- 4.2 Imaging Drug Delivery -- 4.3 Imaging Drug Release -- 4.4 Imaging Drug Efficacy -- 4.5 Conclusions -- 5 The Emerging Field of RNA Nanotechnology -- 5.1 Significance and Uniqueness of RNA Nanotechnology -- 5.2 Distinct Attributes of RNA inside the Body -- 5.3 Techniques for Constructing RNA Nanoparticles -- 5.4 Applications of RNA Nanotechnology -- 5.5 Challenges and Perspectives -- 6 Drug Targeting to Tumors: Principles, Pitfalls and (Pre-) Clinical Progress -- 6.1 Introduction -- 6.2 Principles of Drug Targeting to Tumors -- 6.2.1 Passive Targeting
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 6.2.2 Active Targeting to Cancer Cells -- 6.2.3 Active Targeting to Endothelial Cells -- 6.2.4 Triggered Drug Delivery -- 6.3 Pitfalls in Drug Targeting to Tumors -- 6.3.1 Extravasation and the EPR Effect -- 6.3.2 Penetration -- 6.3.3 Active Targeting -- 6.3.4 Formulation -- 6.3.5 Efficacy vs. Toxicity -- 6.3.6 Metastasis -- 6.3.7 Personalization -- 6.3.8 Translation -- 6.4 (Pre-) Clinical Progress -- 6.5 Conclusion -- 7 Biomolecular Coronas Provide the Biological Identity of Nanosized Materials -- 7.1 Nanoscale Engagement with Biological Processes
520 ## - SUMMARY, ETC.
Summary, etc This book is the second in a series presenting articles that received the most citations in recent years in nanomedicine. The series is edited by, a prominent nanotechnology researcher and editor-in-chief of Precision Nanomedicine. The theme of the second volume is about nano-enabled medical applications. The 19 articles collected here have already acquired more than 12,500 citations highlighting the importance and professional recognition of the work of these scientists in nanomedicine. The content includes the general overview of the field and a wide variety of applications that have been impossible without nanoscience and nanotechnology.
588 ## -
-- OCLC-licensed vendor bibliographic record.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Nanomedicine.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL / Biotechnology
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element SCIENCE / Biotechnology
Source of heading or term bisacsh
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Balogh, Lajos P.,
Relator term editor.
856 40 - ELECTRONIC LOCATION AND ACCESS
Materials specified Taylor & Francis
Uniform Resource Identifier https://www.taylorfrancis.com/books/9780429399039
856 42 - ELECTRONIC LOCATION AND ACCESS
Materials specified OCLC metadata license agreement
Uniform Resource Identifier http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf

No items available.

2017 | The Technical University of Kenya Library | +254(020) 2219929, 3341639, 3343672 | library@tukenya.ac.ke | Haile Selassie Avenue